---

Faculty Gay L. Goss is Professor and nurse practitioner at the United States University in San Diego, California.

Beth M. Kelsey is editor in chief of Women’s Healthcare: A Clinical Journal for NPs , and Director of Publications for the National Association of Nurse Practitioners in Women’s Health .

Heidi Collins Fantasia is Associate Professor and Department Chair at the Solomont School of Nursing in Lowell, Massachusetts, and editor of Nursing for Women’s Health .

Allyssa L. Harris is Dean and Professor, College of Nursing, at Prairie View A&M University in Prairie View, Texas.

Shelagh B. Larson is a provider in the Department of Women and Infants at the Acclaim Multi-Specialty Group, Tarrant County Hospital District, in Fort Worth, Texas.

Jennie Mastroianni is a nurse practitioner in the Department of Obstetrics & Gynecology at Tufts Medical Center and Assistant Clinical Professor in the Department of Obstetrics & Gynecology at Tufts University School of Medicine in Medford, Massachusetts.

Target Audience This continuing education (CE) activity has been designed to meet the educational needs of nurse practitioners and other clinicians who provide healthcare for women.

Approval CE Approval Period: Now through December 31, 2024
Post-tests must be completed during the approval period with a passing score of 70% or higher to earn CE. No refunds will be issued if the activity is not completed within the approval period.
This activity has been approved for 1.0 continuing education contact hours including 0.5 contact hours of pharmacology. 

Objectives

1. Identify clinical indicators and imaging studies helpful in the diagnosis of endometriosis.
2. Discuss a patient-centered approach for relief from symptoms and improved quality of life.
3. Describe indications, mechanism of action, efficacy, adverse events, and contraindication for pharmacologic options in treating endometriosis.

Accreditation Statement This activity has been evaluated and approved by the Continuing Education Approval Program of the National Association of Nurse Practitioners in Women’s Health (NPWH) for 1.0 contact hours including 0.5 contact hours of pharmacology.

Faculty Disclosures The authors have no actual or potential conflicts of interest in relation to the contents of this article, but as journal editor in chief, Dr. Kelsey did not participate in any aspects of peer review or decision on approval of this manuscript

Successful Completion Requires participants to:

1. Read the objectives, disclosures, and disclaimers.
2. Watch the activity and review the handout.
3. Complete the post-test with a score of 70% or higher.
4. Complete the session evaluation.
5. Print your CE certificate.
6. Go to your profile to view all earned certificates.

Conmmercial Support This activity is supported by an educational grant from Myovant Sciences and Pfizer Inc

Pricing:  Free for all.